Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy
Wenlong Liu, Branden S Moriarity, Beau R Webber · 2025
Read Genetic engineering and allogeneic optimization of Vδ1 γδ CAR-T cells (ADI-270) for cancer immunotherapy by Wenlong Liu, Branden S Moriarity, Beau R Webber (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12742126.txt.
Description
Wenlong Liu, Branden Moriarity, and Beau Webber comment on a new engineered cell therapy in a 2025 paper. The therapy uses a less common class of T cells, fitted with a sensor that targets a protein found on some cancers. Extra edits help the cells resist a suppressive signal and avoid rejection when taken from a donor.
The commentary places the work in a wider arc. Tricks first honed in standard CAR-T cells are now being adapted to this cell class. The writers review which of those strategies transfer well and which need rework. They also point to genome-editing advances that could shape the next wave of donor-ready cell therapies for cancer.
Catalog record
| CREATOR | Wenlong Liu, Branden S Moriarity, Beau R Webber |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |